New insights on the antidepressant discontinuation syndrome
ConclusionsThis review raises awareness of the long‐term negative aspects of non‐compliance and inappropriate antidepressant discontinuation, and suggests possible approaches to “design‐out” a risk for ADS. It reveals intuitive and rational ideas for antidepressant drug design, and provides new thoughts on antidepressant pharmacology, ADS risk and how these affect long‐term outcome. Copyright © 2014 John Wiley & Sons, Ltd.
Source: Human Psychopharmacology: Clinical and Experimental - Category: Psychiatry Authors: Brian H. Harvey, Francois N. Slabbert Tags: Review Article Source Type: research
More News: Drugs & Pharmacology | Learning | Neurology | Psychiatry | Universities & Medical Training